Edesa Biotech, Inc.
(NASDAQ : EDSA)

( )
EDSA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Co. 0.00%67.431.0%$732.45m
JNJJohnson & Johnson -1.86%146.700.7%$727.42m
PFEPfizer Inc. 0.25%40.450.9%$573.94m
MRKMerck & Co., Inc. 0.49%90.400.7%$570.77m
ABBVAbbVie, Inc. 0.25%88.222.3%$550.39m
LLYEli Lilly & Co. -0.01%140.911.1%$394.60m
APLSApellis Pharmaceuticals, Inc. 6.27%43.040.0%$117.42m
NVSNovartis AG 0.35%95.520.2%$110.26m
AZNAstraZeneca Plc 0.44%51.021.2%$95.86m
GSKGlaxoSmithKline Plc 0.00%47.500.2%$89.73m
KRTXKaruna Therapeutics, Inc. -0.06%109.230.0%$65.04m
NVONovo Nordisk A/S -0.03%61.130.1%$64.57m
RETAReata Pharmaceuticals, Inc. 0.71%212.933.5%$64.21m
SNYSanofi -0.32%50.050.2%$58.73m
RARXRa Pharmaceuticals, Inc. 0.83%47.250.8%$37.14m

Company Profile

Edesa Biotech, Inc. is a biopharmaceutical company. It focuses on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs. The company was founded in 2015 and is headquartered in Markham, Canada.